A pragmatic approach to streamlining technology and innovating processes will help advance clinical data management.

Results from the pivotal BATURA trial show that Airsupra (albuterol/budesonide) significantly outperformed albuterol ...

If the future of oncology research is to be inclusive, efficient, and representative, community-based clinical trials must be ...

The global, randomized IDeate-Esophageal01 study will evaluate ifinatamab deruxtecan, a B7-H3–targeted antibody-drug conjugate, versus physician’s choice of chemotherapy in patients with advanced or ...

In this video interview, Michael Liu, medical student and researcher at Harvard Medical School, discusses how these cuts are impacting critical areas of clinical research such as staffing and patient ...

Upping the Migraine Intelligence Quotient: RWD sheds light on prevalence rates, providers and treatment variation ...

Upping the Migraine Intelligence Quotient: RWD sheds light on prevalence rates, providers and treatment variation ...

Upping the Migraine Intelligence Quotient: RWD sheds light on prevalence rates, providers and treatment variation ...

Upping the Migraine Intelligence Quotient: RWD sheds light on prevalence rates, providers and treatment variation ...

In the TAK-861-2001 Phase IIb study, oveporexton significantly improved wakefulness, daytime sleepiness, and cataplexy ...

In this video interview, Michael Liu, medical student and researcher at Harvard Medical School, highlights key findings from ...

Welireg (belzutifan), an oral HIF-2α inhibitor, demonstrated an objective response rate of 26% in the LITESPARK-015 study. 1. Regulatory milestone for rare tumors: Merck’s Welireg received FDA ...